triazoles has been researched along with azamulin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Blanchard, AP; Broudy, MI; Cargill, CE; Crespi, CL; Dandeneau, AA; Dehal, SS; Erve, JC; Goodwin, JJ; Ho, T; Patten, CJ; Sharma, R; Stresser, DM; Turner, SD | 1 |
Enomoto, M; Matsui, H; Ohhira, S | 1 |
Alton, KB; Chowdhury, SK; Ghosal, A; Hapangama, N; Kishnani, NS; Ramanathan, R; Yuan, Y | 1 |
Goodman, OB; Mitra, R | 1 |
Sevrioukova, IF | 1 |
Chanteux, H; Delatour, C; Dell'Aiera, S; Gillent, E; Nicolaï, J; Rosa, M; Ungell, AL | 1 |
Hsu, MH; Johnson, EF | 1 |
7 other study(ies) available for triazoles and azamulin
Article | Year |
---|---|
Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible.
Topics: Anti-Infective Agents; Bridged-Ring Compounds; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fluorometry; Humans; In Vitro Techniques; Ketoconazole; Microsomes, Liver; NADP; Pleurotus; Solubility; Steroid Hydroxylases; Substrate Specificity; Triazoles; Xenobiotics | 2004 |
In vitro metabolism of tributyltin and triphenyltin by human cytochrome P-450 isoforms.
Topics: Biotransformation; Bridged-Ring Compounds; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Complementary; Enzyme Inhibitors; Female; Humans; Isoenzymes; Liver; Male; Mephenytoin; Microsomes, Liver; Organotin Compounds; Recombinant Proteins; Trialkyltin Compounds; Triazoles | 2006 |
Identification of human liver cytochrome P450 enzymes involved in biotransformation of vicriviroc, a CCR5 receptor antagonist.
Topics: Antibodies, Monoclonal; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bridged-Ring Compounds; Carboxylic Acids; CCR5 Receptor Antagonists; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dealkylation; Enzyme Inhibitors; Humans; Immunologic Factors; In Vitro Techniques; Isoenzymes; Ketoconazole; Kinetics; Liver; Oxidation-Reduction; Piperazines; Pyrimidines; Recombinant Proteins; Substrate Specificity; Testosterone; Triazoles | 2007 |
CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR.
Topics: Blotting, Western; Bridged-Ring Compounds; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dihydrotestosterone; Fluorescent Antibody Technique; Humans; Male; Metribolone; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Androgen; RNA, Small Interfering; Signal Transduction; Triazoles | 2015 |
Structural Insights into the Interaction of Cytochrome P450 3A4 with Suicide Substrates: Mibefradil, Azamulin and 6',7'-Dihydroxybergamottin.
Topics: Bridged-Ring Compounds; Crystallography, X-Ray; Cytochrome P-450 CYP3A; Furocoumarins; Humans; Mibefradil; Models, Molecular; Substrate Specificity; Triazoles | 2019 |
Application of Azamulin to Determine the Contribution of CYP3A4/5 to Drug Metabolic Clearance Using Human Hepatocytes.
Topics: Bridged-Ring Compounds; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Evaluation, Preclinical; Drug Interactions; Hepatobiliary Elimination; Hepatocytes; Humans; Liver; Microsomes, Liver; Primary Cell Culture; Triazoles | 2020 |
Structural characterization of the homotropic cooperative binding of azamulin to human cytochrome P450 3A5.
Topics: Bridged-Ring Compounds; Catalytic Domain; Cytochrome P-450 CYP3A; Humans; Triazoles | 2022 |